Recommendation from Healthcare and Metals & Mining Sector

The scrips in this column have been recommended with a 15-day investment horizon in mind and carry high risk. Therefore, investors are advised to take into account their risk appetite before investing, as fundamentals may or may not back the recommendations.[EasyDNNnews:PaidContentStart]

Laurus Labs Ltd
CMP - ₹884.65
BSE CODE 540222
Volume 45,766
Face Value ₹2
Target ₹955 - ₹973
Stoploss ₹823 (CLS)

Laurus Labs is a research-driven pharmaceutical and biotech powerhouse, specializing in active pharmaceutical ingredients (APIs), finished formulations, CDMO services, and biotech offerings such as precision fermentation and oncology APIs. It boasts a diversified global presence and approvals from bodies like the USFDA and WHO. With a growing R&D pipeline, the company is cementing its position in high-growth segments including generics, contract manufacturing, and biotechnology. In Q1FY26, Laurus Labs posted a robust 31 per cent year-on-year revenue growth to ₹1,570 crore, while net profit surged sharply from ₹13 crore in the corresponding quarter last year to ₹162 crore. Shares of Laurus Labs have been on a strong uptrend after the Andhra Pradesh government allotted 531.77 acres in IP Rambilli Phase-II, Anakapalli District, for the establishment of Laurus Pharma Zone (LPZ), aimed at setting up pharma manufacturing units. Shares have already delivered 100 per cent returns over the past year, and with further upside potential, we recommend BUY.

Godawari Power & Ispat Ltd
CMP - ₹215.90
BSE CODE 532734
Volume 9,36,423
Face Value ₹1
Target ₹233 - ₹237
Stoploss ₹200 (CLS)

Godawari Power & Ispat is an integrated steel and power company and a part of the Hira Group. Its operations cover the entire value chain from iron ore mining and sponge iron production to billets, mild steel wires and ferro alloys, supported by captive power generation and renewable energy initiatives. Shares of the company have surged around 10 per cent in the past five trading sessions following an update on its investment plans. The board has approved setting up a Battery Energy Storage System (BESS) plant with an initial capacity of 10 GWh for manufacturing battery packs and containers through its wholly owned subsidiary, Godawari New Energy Pvt. Ltd. With falling technology costs, policy levers, and surging renewable penetration, India's Battery Energy Storage Systems (BESS) segment is set to become a cornerstone of India’s energy transition, offering immense opportunities for strategic investors and infrastructure players alike. Hence, considering the increased investor buying interest and strong growth potential, we recommend BUY.

[EasyDNNnews:PaidContentEnd] [EasyDNNnews:UnPaidContentStart]

[EasyDNNnews:UnPaidContentEnd]